Skip to main content
Caplight Logo









iMedicina

iMedicina

Private
Belo HorizonteHealthcare & Life Scienceshttps://imedicina.com.br/

Last Round

M&A

Oct 23, 2020

Est. Valuation

$10M

Total Funding Raised

$2.93M

Company Overview

iMedicina operates in Healthcare & Life Sciences and is based in Belo Horizonte. Its latest recorded funding round was a Series A round in May 2018.

iMedicina is a health-tech company that provides an integrated medical software platform for clinical management, patient engagement, and medical marketing.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Telemedicine, Patient Engagement, Vertical SaaS, CRM

Business Model

B2B

Customer Profile

Freemium, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

iMedicina Comparables

Compare iMedicina with similar companies based on industry and business-model similarity.

iMedicina comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GestãoDS
89%
Ninsaúde
87%
ByDoctor
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

iMedicina Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AOct 23, 2020
Series AMay 18, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

iMedicina Investors

Notable investors and investment history

iMedicina investors
InvestorRounds
Cedro CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 23, 2020

    Raised $2.84M with Conexa Saúde

  • May 18, 2018

    $3M round led by Cedro Capital

Book a demo to see all signals

For institutional investors. Book with your work email.

iMedicina Filings

Explore SEC and related filing metadata, where available.

iMedicina filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about iMedicina's valuation, stock price, and market status.

Is iMedicina a public or private company?

iMedicina is a private company.

What is the current stock price of iMedicina?

iMedicina is a private company, so its shares have no public market price. Caplight tracks iMedicina's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is iMedicina worth (valuation)?

iMedicina's valuation is estimated at $10.0M based on funding round data.

Can I buy iMedicina stock?

iMedicina shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was iMedicina's last funding round?

iMedicina's most recent funding round was M&A on October 23, 2020.

Who are the main investors in iMedicina?

Key investors in iMedicina include Cedro Capital.

Will iMedicina IPO soon?

No public IPO plans have been announced for iMedicina.

How can I track iMedicina secondary market activity?

Caplight tracks bids, offers, and trades in iMedicina's shares on secondary markets.

Firmographic Details

HeadquartersBelo Horizonte
Employee Range12
Year Founded2016
Last FundingOct 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?